FDA weighs first-ever OTC birth control pill
Jul 13, 2022•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The Food and Drug Administration is reviewing a first-of-its-kind application from HRA Pharma for Opill. If green-lit by the agency, Opill would become the first daily, hormonal birth control pill sold without a prescription. The submission of the application follows more than six years of studies the company has run. Alice Miranda Ollstein reports.
Learn more about your ad choices. Visit megaphone.fm/adchoices
For the best experience, listen in Metacast app for iOS or Android